Микробиота глазной поверхности: методы исследования и современные представления о взаимосвязи дисбиоза кишечника и офтальмопатологии

    1. Ueta M, Kinoshita S. Innate immunity of the ocular surface. Brain Res Bull. 2010 Feb 15;81(3–3): 219–228. doi: 10.1016/j. brainresbull.2009.10.001

    2. Lu LJ, Liu J. Human Microbiota and Ophthalmic Disease. Yale J Biol Med. 2016 Sep;89(3): 325–330.

    3. Резбаева Г.Н., Оренбуркина О.И., Гимранова И.А., Бабушкин А.Э. О микробиоме глазной поверхности. Точка зрения. Восток – Запад. 2023;10(3): 38–44. [Rezbayeva GN, Orenburkina OI, Gimranova IA, Babushkin AE. O mikrobiome glaznoy poverkhnosti. Tochka zreniya. Vostok – Zapad. 2023;10(3): 38–44. (In Russ.)] doi: 10.25276/2410-1257- 2023-3-38-44

    4. Kugadas A, Wright Q, Geddes-McAlister J, Gadjeva M. Role of microbiota in strengthening ocular mucosal barrier function through secretory IgA. Invest Ophthalmol Vis Sci. 2017;58(11): 4593–4600. doi: 10.1167/iovs.17-22119

    5. Cabuoto KM, Banerjee S, Miller D, Galor A. Composition and Comparison of the Ocular Surface Microbiome in Infants and Older Children.Translational Vision Science & Technology. 2018;7(6): 16. doi: 10.1167/tvst.7.6.16

    6. Ozkan J, Willcox MD. The Ocular Microbiome: Molecular Characterization of a Unique and Low Microbial Environment. Current Eye Research. 2019;44(7): 685–694. doi: 10.1080/02713683.2019.1570526

    7. Petrillo F, Pignataro D, Lavano MA, et al. Current Evidence on the Ocular SurfaceMicrobiota and Related Diseases. Microorganisms. 2020;8(7): 1033. doi: 10.3390/microorganisms8071033

    8. Miller D, Iovieno A. The role of microbial flora on the ocular surface. Curr Opin Allergy Clin Immunol. 2009;9(5): 466–470. doi: 10.1097/ACI.0b013e3283303e1b

    9. Wu T, Mitchell B, Carothers T, Coats D, Brady-McCreery K, Paysse E, Wilhelmus K. Molecular analysis of the pediatric ocular surface for fungi. Curr Eye Res. 2003;26(1): 33–36. doi: 10.1076/ceyr.26.1.33.14253

    10. Dong Q, Brulc JM, Iovieno A, Bates B, Garoutte A, Miller D, Revanna KV, Gao X, Antonopoulos DA, Slepak VZ, et al. Diversity of bacteria at healthy human conjunctiva. Investig Ophthalmol Vis Sci. 2011;52(8): 5408–5413. doi: 10.1167/iovs.10- 6939

    11. Zhou Y, Holland MJ, Makalo P, Joof H, Roberts CH, Mabey DC, Bailey RL, Burton MJ, Weinstock GM, Burr SE. The conjunctival microbiome in health and trachomatous disease: A case control study. Genome Med. 2014;6(11): 99. doi: 10.1186/s13073- 014-0099-x

    12. Huang Y, Yang B, Li W. Defining the normal core microbiome of conjunctival microbial communities. Clin Microbiol Infect. 2016;22(7): 643.e7–643.e12. doi: 10.1016/j.cmi.2016.04.008

    13. Doan T, Akileswaran L, Andersen D, Johnson B, Ko N, Shrestha A, et al. Paucibacterial Microbiome and Resident DNA Virome of the Healthy Conjunctiva. Invest Ophthalmol Vis Sci. 2016;57(13): 5116–5126. doi: 10.1167/iovs.16-19803

    14. Ozkan J, Nielsen S, Diez-Vives C, Coroneo M, Thomas T, Willcox M. Temporal stability and composition of the ocular surface microbiome. Sci Rep. 2017;7(1): 9880. doi: 10.1038/ s41598-017-10494-9

    15. Юдин С.М., Егорова А.М., Макаров В.В. Анализ микробиоты человека: российский и зарубежный опыт. Международный журнал прикладных и фундаментальных исследований. 2018;11(1): 175–180. [Yudin SM, Yegorova AM, Makarov VV. Analiz mikrobioty cheloveka: rossiyskiy i zarubezhnyy opyt. Mezhdunarodnyy zhurnal prikladnykh i fundamental’nykh issledovaniy. 2018;11(1): 175–180. (In Russ.)]

    16. Юдина Ю.В., Корсунский А.А., Аминова А.И., Абдуллаева Г.Д., Продеус А.П. Микробиота кишечника как отдельная система организма. Доказательная гастроэнтерология. 2019;8(4–5): 36–43. [Yudina YuV, Korsunsky AA, Aminova AI, Abdullaeva GD, Prodeus AP. Gut microbiota as a separate body system. Russian Journal of Evidence-Based Gastroenterology .2019;8(4): 36–43. (In Russ.)] doi: 10.17116/dokgastro2019804-136

    17. Резбаева Г.Н., Бабушкин А.Э., Оренбуркина О.И., Гимранова И.А. Связь развития и прогрессирования различной офтальмопатологии с состоянием микробиома кишечника. РМЖ. Клиническая офтальмология. 2023;23(4): 219–223. [Rezbaeva GN, Babushkin AE, Orenburkina OI, Gimranova IA. The relationship between the development and progression of various ophthalmopathologies and the state of the intestinal microbiome. RMJ. Clinical ophthalmology. 2023;23(4): 219–223. (In Russ.)] doi: 10.32364/2311-7729-2023-23-4-8

    18. Suriguga S, Luangmonkong T, Mutsaers HAM, Groothuis GMM, Olinga P. Host microbiota dictates the proinflammatory impact of LPS in the murine liver. Toxicol In Vitro. 2020;67: 104920. doi: 10.1016/j.tiv.2020.104920

    19. Kinross JM, von Roon AC, Holmes E, Darzi A, Nicholson JK. The human gut microbiome: Implications for future health care. Curr Gastroenterol Rep. 2008;10(4): 396–403. doi: 10.1007/ s11894-008-0075-y

    20. Flint HJ, Scott KP, Louis P, Duncan SH. The role of gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol. 2012;9(10): 577–589. doi: 10.1038/nrgastro.2012.156

    21. Pflughoeft KJ, Versalovic J. Human microbiome in health and disease. Annu Rev Pathol Mech Dis. 2012;7: 99–122. doi: 10.1146/annurev-pathol-011811-132421

    22. Delzenne NM, Cani PD, Everard A, Neyrinck AM, Bindels LB. Gut microorganisms as promising targets for the management of type 2 diabetes. Diabetologia. 2015 Oct;58(10): 2206–2217. doi: 10.1007/s00125-015-3712-7

    23. Petrov VA, Saltykova IV, Zhukova IA, et al. Analysis of Gut Microbiota in Patients with Parkinson’s Disease. Bull Exp Biol Med. 2017;162(6): 734–737. doi: 10.1007/s10517-017- 3700-7

    24. Бабаев Э.А., Балмасова И.П.., Мкртумян А.М., Кострюкова С.Н., Вахитова Е.С., Ильина Е.Н., Царев В.Н., Габибов А.Г., Арутюнов С.Д. Метагеномный анализ микробиоты зубодесневой борозды и патогенез пародонтита, ассоциированного с сахарным диабетом 2-го типа. 2017;163(6): 682– 686. [Babaev EA, Balmasova IP, Mkrtumyan AM, Kostryukova SN, Vakhitova ES, Ilyina EN, Tsarev VN, Gabibov AG, Arutyunov SD. Metagenomic analysis of the microbiota of the periodontal sulcus and the pathogenesis of periodontitis associated with type 2 diabetes mellitus. 2017;163(6): 682–686. (In Russ.)]

    25. Leustean AM, Ciocoiu M, Sava A, Costea CF, Floria M, Tarniceriu CC, Tanase DM. Implications of the intestinal microbiota in diagnosing the progression of diabetes and the presence of cardiovascular complications. J Diabetes Res. 2018;2018: 5205126. doi: 10.1155/2018/5205126

    26. Kasselman LJ, Vernice NA, DeLeon J, Reiss AB. The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity. Atherosclerosis. 2018;271: 203–213. doi: 10.1016/j. atherosclerosis.2018.02.036

    27. Ferreri AJ, Dolcetti R, Magnino S, Doglioni C, Ponzoni M. Chlamydial infection: the link with ocular adnexal lymphomas. Nat Rev Clin Oncol. 2009 Nov;6(11): 658–669. doi: 10.1038/ nrclinonc.2009.147

    28. de Paiva CS, Jones DB, Stern ME, Bian F, Moore QL, Corbiere S, Streckfus CF, Hutchinson DS, Ajami NJ, Petrosino JF, Pflugfelder SC. Altered mucosal microbiome diversity and disease severity in sjögren syndrome. Sci Rep. 2016;6: 23561. doi: 10.1038/srep23561

    29. Zinkernagel MS, Zysset-Burri DC, Keller I, Berger LE, Leichtle AB, Largiadèr CR, Fiedler GM, Wolf S. Association of the intestinal microbiome with the development of neovascular age-related macular degeneration. Sci Rep. 2017;7: 40826. doi: 10.1038/srep40826

    30. Rosenbaum JT, Asquith M. The microbiome and HLA-B27-associated acute anterior uveitis. Nat Rev Rheumatol. 2018;14(12): 704–713. doi: 10.1038/s41584-018-0097-2

    31. Tsigalou C, Stavropoulou E, Bezirtzoglou E. Current insights in microbiome shifts in sjogren’s syndrome and possible therapeutic interventions. Front Immunol. 2018;9: 1106. doi: 10.3389/fimmu.2018.01106

    32. Zaheer M, Wang C, Bian F, Yu Z, Hernandez H, de Souza RG, Simmons KT, Schady D, Swennes AG, Pflugfelder SC, Britton RA, de Paiva CS. Protective role of commensal bacteria in Sjögren Syndrome. J Autoimmun. 2018;93: 45–56. doi: 10.1016/j.jaut.2018.06.004

    33. Rinninella E, Mele MC, Merendino N, Cintoni M, Anselmi G, Caporossi A, Gasbarrini A, Minnella AM. The role of diet, micronutrients and the gut microbiota in age-related macular degeneration: new perspectives from the gut-retina Axis. Nutrients. 2018;10(11): E1677. doi: 0.3390/nu10111677

    34. Zhang Y, Zhou X , Lu Yi. Gut microbiota and derived metabolomic profiling in glaucoma with progressive neurodegeneration. Front Cell Infect Microbiol. 2022;12: 968992. doi: 10.3389/fcimb.2022.968992

    35. Chakravarthy SK, Jayasudha R, Ranjith K, Dutta A, Pinna NK, Mande SS, Sharma S, Garg P, Murthy SI, Shivaji S. Alterations in the gut bacterial microbiome in fungal Keratitis patients. PLoS One. 2018;13(6): e0199640.

    36. Napolitano P, Filippelli M, Davinelli S, Bartollino S, dell’Omo R, Costagliola C. Influence of gut microbiota on eye diseases: an overview. Ann Med. 2021 Dec;53(1): 750–761. doi: 10.1080/07853890.2021.1925150

    37. Pezzino S, Azienda MS, Cannizzaro O, et al. Microbiome Dysbiosis: A athological Mechanism at the Intersection of Obesity and Glaucoma. January International Journal of Molecular Sciences. 2023;24(2): 1166. doi: 10.3390/ ijms24021166

    38. Gower EW, Lindsley K, Nanji AA, et al. Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery. Cochrane Database Syst Rev. 2013;7(7): CD006364. doi: 10.1002/14651858.CD006364.pub2